Literature DB >> 10181680

The health of overseas-born Australians, 1994-1996.

K Strong, P Trickett, K Bhatia.   

Abstract

Analysis of mortality, hospital separations and self-reported health indicators by country of birth group has confirmed that overseas-born populations are generally in better health than their Australian-born contemporaries. The better health of the overseas-born may be reflected in both the willingness and eligibility of individuals to emigrate. Overseas-born individuals were placed into one of four groups according to place of birth. These included the United Kingdom and Ireland, Other Europe, Asia and Other. All population groups reported lower mortality and hospitalisation rates for all causes of disease combined. The Asian-born population had the lowest mortality rates with 38% less mortality for males and 30% less for females. Hospitalisation rates were also lower for the Asian-born, with males and females having 46% and 37% fewer hospital separations compared to the Australian-born population. However, diabetes mortality was greater for males and females from Other Europe, Asia and Other regions. Both males and females from the United Kingdom and Ireland group showed increased mortality from lung cancer. Mortality and hospitalisation for cervical cancer was also significantly higher for Asian-born and Other females. The mortality and hospitalisation data corresponded well with self-reported prevalence of health-related risk factors. For example, self-reported diabetes prevalence was higher for the Other Europe, Asia and Other groups. Asian and Other females reported significantly less use of regular Pap smear tests, reflecting their increased mortality and hospitalisation for cervical cancer. These results support the finding of past studies that the health of migrants is generally better than that of the Australian-born population and reflects a 'healthy migrant' effect.

Entities:  

Mesh:

Year:  1998        PMID: 10181680     DOI: 10.1071/ah980124

Source DB:  PubMed          Journal:  Aust Health Rev        ISSN: 0156-5788            Impact factor:   1.990


  7 in total

1.  Migration and Pacific mortality: estimating migration effects on Pacific mortality rates using Bayesian models.

Authors:  Ken Richardson; Santosh Jatrana; Martin Tobias; Tony Blakely
Journal:  Demography       Date:  2013-12

2.  Convergence of body mass index of immigrants to the Canadian-born population: evidence from the National Population Health Survey (1994-2006).

Authors:  Maninder Singh Setia; Amelie Quesnel-Vallee; Michal Abrahamowicz; Pierre Tousignant; John Lynch
Journal:  Eur J Epidemiol       Date:  2009-07-30       Impact factor: 8.082

3.  Higher mortality and different pattern of causes of death among foreign-born compared to native Swedes 1970-1999.

Authors:  Björn Albin; Katarina Hjelm; Jan Ekberg; Sölve Elmståhl
Journal:  J Immigr Minor Health       Date:  2006-04

4.  Does mortality vary between Asian subgroups in New Zealand: an application of hierarchical Bayesian modelling.

Authors:  Santosh Jatrana; Ken Richardson; Tony Blakely; Saira Dayal
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

5.  Analysis of in-hospital mortality among people with and without diabetes in South Western Sydney public hospitals (2014-2017).

Authors:  Tina Gao; Kingsley E Agho; Milan K Piya; David Simmons; Uchechukwu L Osuagwu
Journal:  BMC Public Health       Date:  2021-11-03       Impact factor: 3.295

6.  Representations and coverage of non-English-speaking immigrants and multicultural issues in three major Australian health care publications.

Authors:  Pamela W Garrett; Hugh G Dickson; Anna Klinken Whelan; Linda Whyte
Journal:  Aust New Zealand Health Policy       Date:  2010-01-03

7.  The rural bite in population pyramids: what are the implications for responsiveness of health systems in middle income countries?

Authors:  Nowrozy Jahan; Pascale Allotey; Dharma Arunachalam; Shajahan Yasin; Ireneous N Soyiri; Tamzyn M Davey; Daniel D Reidpath
Journal:  BMC Public Health       Date:  2014-06-20       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.